Related Experiment Video
Updated: Jul 19, 2026

TIRFM and pH-sensitive GFP-probes to Evaluate Neurotransmitter Vesicle Dynamics in SH-SY5Y Neuroblastoma Cells: Cell Imaging and Data Analysis
Published on: January 29, 2015
The VIP-receptor system in neuroblastoma cells
Jean-Marc Muller1, Michel Philippe, Lucie Chevrier
1Institut de Physiologie et Biologie Cellulaires, CNRS UMR6187, Université de Poitiers, Pôle Biologie Santé, 40 Avenue du Recteur Pineau, 86022 Poitiers CEDEX, France. jean-marc.muller@univ-poitiers.fr <jean-marc.muller@univ-poitiers.fr>
Neuroblastoma, a childhood cancer, can spontaneously regress. This review explores how vasoactive intestinal peptide (VIP) and its receptors influence neuroblastoma cell behavior, offering potential therapeutic targets.
Area of Science:
- Pediatric Oncology
- Developmental Neurobiology
- Cancer Cell Biology
Background:
- Neuroblastoma (NB) is the most common pediatric extracranial tumor, originating from the sympathetic nervous system.
- NB exhibits spontaneous regression and is characterized by neuroblastic (N-type) and nonneuronal cell subpopulations.
- TrkA receptor expression correlates with good prognosis, while MYCN amplification indicates advanced disease.
Purpose of the Study:
- To review the production of vasoactive intestinal peptide (VIP) and related peptides in NB.
- To examine the expression of VIP receptors in neuroblastoma.
- To summarize the regulatory role of the VIP-receptor system in controlling NB cell behavior.
Main Methods:
- Literature review of existing data on VIP, its receptors, and their role in neuroblastoma.
- Analysis of studies investigating the effects of VIP and related peptides on NB cell differentiation and behavior.
- Synthesis of information regarding signaling pathways modulated by the VIP-receptor system in NB.
Main Results:
- VIP and related peptides are produced in NB, and their receptors are expressed on NB cells.
- VIP signaling influences NB cell proliferation, differentiation, and maturation.
- The VIP-receptor system plays a key regulatory role in neuroblastoma cell behavior.
Conclusions:
- The VIP-receptor system is a crucial regulator of neuroblastoma cell biology.
- Targeting VIP signaling pathways presents a promising therapeutic strategy for neuroblastoma.
- Further research into VIP-receptor interactions could lead to novel treatments for this childhood cancer.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...